LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_005245.4:c.4516C>T
FAT1
· NP_005236.2:p.(Arg1506Cys)
· NM_005245.4
GRCh37: chr4:187549725 G>A
·
GRCh38: chr4:186628571 G>A
Gene:
FAT1
Transcript:
NM_005245.4
Final call
VUS
Variant details
Gene
FAT1
Transcript
NM_005245.4
Protein
NP_005236.2:p.(Arg1506Cys)
gnomAD AF
0.00082529312776182 (v4.1)
ClinVar
Uncertain significance
OncoKB
Unknown Oncogenic Effect
Classification rationale
Interpretation summary
Generated evidence synthesis
1
None of PS1, PM1, PM5, PP2, or BP1 can be concluded from the supplied evidence because the required same-residue pathogenic comparators, validated domain or hotspot route, gene-level missense mechanism, or truncating-variant predominance are not established.
2
No VCEP covers FAT1 in this case; the requested criteria were evaluated under generic ACMG/AMP 2015 definitions.
3
No exact-variant expert-panel ClinVar Pathogenic/Likely pathogenic or Benign/Likely benign classification was found, so PP5 and BP6 are not met.
4
FAT1 has no VCEP in this case, so generic ACMG/AMP rules govern.
5
The variant is missense; PP3 and BP4 therefore use the REVEL path only, with no cross-use of SpliceAI or BayesDel.
6
REVEL 0.341 is in the gray zone: below all PP3 thresholds and above all BP4 thresholds.
7
PP3 and BP4 are both applicable but not met; no other criteria were adjudicated.
Final determination:
Under the generic ACMG/AMP 2015 fallback, no pathogenic, likely pathogenic, benign, or likely benign combination threshold is satisfied, so the variant is classified as VUS.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | N/A | Not applicable: PVS1 requires a null variant (nonsense, frameshift, canonical splice, start-loss or stop-loss), and this is a missense variant. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| PS1 | Not assessed | Not assessed: no previously established pathogenic variant with the same Arg1506Cys amino-acid change was identified in the supplied evidence. |
clinvar
pm5_candidates
PMID:25741868
|
| PS2 | Not assessed | Not assessed: no documented proband de novo observation with confirmed maternity and paternity, disease phenotype, and absent family history. |
|
| PS3 | Not assessed | Not assessed: no variant-specific validated functional assay or reviewed functional result was available for FAT1 p.Arg1506Cys. |
oncokb
|
| PS4 | Not assessed | Not assessed: PMID:34598035 provides no variant-specific case/control counts, OR, or confidence interval needed to test OR >5.0 with a CI excluding 1.0. |
PMID:34598035
|
| PM1 | Not assessed | Not assessed: FAT1 R1506 has no supplied critical-domain evidence, no Cancer Hotspots result, and no demonstrated absence of benign variation. |
hotspots
cosmic
PMID:25741868
|
| PM2 | Not met | Not met: gnomAD v4.1 total AF is 0.000825293, above the generic PM2 supporting cutoff of 0.0001, with 1,332 observed alleles. |
gnomad_v4
gnomad_v2
|
| PM3 | Not assessed | Not assessed: no affected-proband observation, pathogenic partner allele, or parental/offspring testing establishes a recessive trans configuration. |
clinvar
PMID:25741868
|
| PM4 | N/A | Not applicable: PM4 requires a protein-length change, and this is a missense variant. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| PM5 | Not assessed | Not assessed: no different missense variant at Arg1506 is established as pathogenic in the supplied evidence. |
pm5_candidates
clinvar
PMID:25741868
|
| PM6 | Not assessed | Not assessed: no documented assumed de novo observation in a proband with a relevant disease phenotype or reported parental testing. |
|
| PP1 | Not assessed | Not assessed: no affected family members or variant-positive meioses are documented to evaluate co-segregation with disease. |
|
| PP2 | Not assessed | Not assessed: FAT1 missense mechanism and low benign-missense rate are not jointly established by the supplied evidence. |
gnomad_v4
oncokb
pvs1_gene_context
PMID:25741868
|
| PP3 | Not met | Not met: missense REVEL 0.341 is below the PP3 supporting threshold of 0.644. |
revel
PMID:25741868
|
| PP4 | Not assessed | Not assessed: no patient phenotype or family-history information is available to determine whether it is highly specific for a single-gene disease. |
|
| PP5 | Not met | Not met: ClinVar reports the exact variant as Uncertain significance in six submissions with zero expert-panel classifications, not Pathogenic or Likely pathogenic. |
clinvar
|
| BA1 | Not met | Not met: gnomAD v4.1 grpmax FAF is 0.00099187, far below the generic BA1 threshold of 0.05, using 62,490 observed alleles. |
gnomad_v4
gnomad_v2
|
| BS1 | Not met | Not met: gnomAD v4.1 grpmax FAF is 0.00099187, below the generic BS1 threshold of 0.01, with 62,490 observed alleles. |
gnomad_v4
gnomad_v2
|
| BS2 | Not assessed | Not assessed: gnomAD reports zero homozygotes but does not establish healthy-adult status, inheritance model, or early-age full penetrance for FAT1 disease. |
gnomad_v4
gnomad_v2
|
| BS3 | Not assessed | Not assessed: no variant-specific validated functional assay or reviewed neutral result was available for FAT1 p.Arg1506Cys. |
oncokb
|
| BS4 | Not assessed | Not assessed: no tested affected relatives or genotype-negative affected family members are documented to demonstrate lack of segregation. |
|
| BP1 | Not assessed | Not assessed: FAT1 loss-of-function evidence is present, but predominance of truncating disease variants over missense variants is not established. |
pvs1_gene_context
PMID:25741868
|
| BP2 | Not assessed | Not assessed: no evidence shows this variant in trans with a pathogenic dominant- disorder allele or in cis with any pathogenic allele. |
clinvar
PMID:25741868
|
| BP3 | N/A | Not applicable: BP3 requires an in-frame indel in a repeat region, and this is a missense variant. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| BP4 | Not met | Not met: missense REVEL 0.341 exceeds the BP4 supporting threshold of 0.29, so SpliceAI cannot substitute. |
revel
PMID:25741868
|
| BP5 | Not assessed | Not assessed: no affected case is documented with this variant and an independently established alternate molecular basis for disease. |
|
| BP6 | Not met | Not met: ClinVar reports the exact variant as Uncertain significance in six submissions with zero expert-panel classifications, not Benign or Likely benign. |
clinvar
|
| BP7 | N/A | Not applicable: BP7 requires a synonymous variant, and this is a missense variant. |
generic_acmg_combination_rules
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.